---
figid: PMC7054554__41467_2020_14962_Fig8_HTML
figlink: pmc/articles/PMC7054554/figure/Fig8/
number: F8
caption: The mechanistic target of the rapamycin (mTOR) pathway is a central regulator
  of cell growth and metabolism. A variety of upstream signals regulate mTOR activity,
  including growth factors and nutrients. Activation of receptor tyrosine kinases
  (RTKs) by growth factors activates the PI3K/AKT pathway as well as the RAS and MEK/ERK
  pathway, which promote mTORC1 activation. Chronic rapamycin treatment inhibits mTORC1
  activity and in some cell types also mTORC2 activity. In telomerase-deficient mice
  with short telomeres, the G2 Terc−/− mice, the RAS and PI3K/AKT pathways are upregulated
  concomitantly with increased mTORC1 activity and increased levels of the mTORC1
  downstream target pS6. The results shown here support a model in which hyperactivation
  of these metabolic-related pathways as the consequence of telomerase deficiency
  and short telomeres constitute a compensatory survival mechanism in response to
  the telomeric defects. In agreement with this, inhibition of the mTOR pathway by
  chronic rapamycin treatment or by genetic deletion of S6K1 is deleterious for telomerase-deficient
  mice.
pmcid: PMC7054554
papertitle: The mTOR pathway is necessary for survival of mice with short telomeres.
reftext: Iole Ferrara-Romeo, et al. Nat Commun. 2020;11:1168.
pmc_ranked_result_index: '41159'
pathway_score: 0.9407465
filename: 41467_2020_14962_Fig8_HTML.jpg
figtitle: MTOR pathway is necessary for survival of mice with short telomeres
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7054554__41467_2020_14962_Fig8_HTML.html
  '@type': Dataset
  description: The mechanistic target of the rapamycin (mTOR) pathway is a central
    regulator of cell growth and metabolism. A variety of upstream signals regulate
    mTOR activity, including growth factors and nutrients. Activation of receptor
    tyrosine kinases (RTKs) by growth factors activates the PI3K/AKT pathway as well
    as the RAS and MEK/ERK pathway, which promote mTORC1 activation. Chronic rapamycin
    treatment inhibits mTORC1 activity and in some cell types also mTORC2 activity.
    In telomerase-deficient mice with short telomeres, the G2 Terc−/− mice, the RAS
    and PI3K/AKT pathways are upregulated concomitantly with increased mTORC1 activity
    and increased levels of the mTORC1 downstream target pS6. The results shown here
    support a model in which hyperactivation of these metabolic-related pathways as
    the consequence of telomerase deficiency and short telomeres constitute a compensatory
    survival mechanism in response to the telomeric defects. In agreement with this,
    inhibition of the mTOR pathway by chronic rapamycin treatment or by genetic deletion
    of S6K1 is deleterious for telomerase-deficient mice.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - MAP2K1
  - MAP2K2
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - MTOR
  - RPS6KB1
  - rapamycin
  - "deficiency \x1F Decreased cancer"
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
chemicals:
- word: rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: "deficiency \x1F Decreased cancer"
  source: MESH
  identifier: D009369
figid_alias: PMC7054554__F8
redirect_from: /figures/PMC7054554__F8
figtype: Figure
---
